Asthma Control and Atrial Fibrillation Risk: Is There a Link?

July 13, 2018

Dose-response association seen between levels of asthma control and risk of atrial fibrillation

Patient Engagement in Asthma Treatment Plans May Improve Quality of Life

July 02, 2018

In older adults with asthma, decision making scores positively correlated with QoL scores

Psychosis Could Be a Potential Side Effect of Steroid Treatment in Kids

By April 12, 2018

Iatrogenic steroid-induced psychosis is a rare side effect of glucocorticoid therapy which is mostly seen in adults, although it has been reported in children and adolescents.

Smartinhaler Sensor for Symbicort Will Be Available Over-the-Counter

By March 27, 2018

The Smartinhaler sensor is a device installed onto a patient's inhaler to monitor and promote asthma and COPD medication adherence.

SCIT May Cut Long-Term Asthma Med Use in Pediatric Allergic Asthma

By March 26, 2018

Allergen avoidance, drug therapy, and allergen immunotherapy are all treatment options for allergic asthma.

Dupilumab Under FDA Review for Moderate-to-Severe Asthma

By March 02, 2018

Dupixent is a human monoclonal antibody specifically designed to inhibit signaling of interleukin-4 (IL-4) and interleukin-13 (IL-13), two important signaling proteins (cytokines) that contribute to Type 2 inflammation in moderate-to-severe asthma.

Treatment Options for Patients With Severe Asthma

By February 16, 2018

Severe asthma is a challenging condition. Available therapeutic options for severe asthma include tiotropium, omalizumab, interleukin-5 targeted therapies, macrolide antibiotics, and bronchial thermoplasty.

Breath-Actuated Qvar RediHaler Available for Asthma Maintenance Treatment

By February 12, 2018

Qvar RediHaler (beclomethasone dipropionate HFA) Inhalation Aerosol is a breath-actuated inhaled prescription medicine used as a maintenance treatment for the prevention and control of asthma in people 4 years of age and older.

Asthma Guideline Adherence, Agreement Assessed Among PCPs, Specialists

By February 09, 2018

To examine real-world clinician adherence to these guidelines, as well as agreement and self-efficacy, researchers analyzed data from the 2012 National Asthma Survey of Physicians.

Asthma Treatment Aerospan Has Been Discontinued

By January 29, 2018

Both the 60- and 120-actuation sizes have been discontinued.

CDC: Certain Occupations Linked to Elevated Asthma Mortality

By January 19, 2018

The food, beverage and tobacco manufacturing industry (1.82) had the highest elevated asthma PMRs for men. Among women, the social assistance industry (1.35) and community social services occupations (1.46) had the highest elevated asthma PMRs.

Fasenra Approved for Severe Eosinophilic Asthma

By November 15, 2017

Fasenra is indicated for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

Does Inhaled Corticosteroid Use Up the Risk of Fracture in Children?

November 14, 2017

Inhaled corticosteroids are not associated with increased odds of fracture in the pediatric asthma population

Dupilumab Beneficial for Patients with Severe Steroid-Dependent Asthma

By October 31, 2017

Consistent reductions in asthma attacks and improvements in lung function across a broad population of uncontrolled asthma patients.

Asthma Drug Linked to Neuropsychiatric Adverse Events

By September 21, 2017

Results found that overall depression was the most commonly reported adverse event in the VigiBase group while headaches were the most frequent adverse event reported for the Dutch database.

Xolair Re-Treatment Still Effective in Chronic Spontaneous Urticaria

By September 19, 2017

Among the re-treated patients, almost 90% achieved symptom control (UAS7 ≤6) within 3 months. During both dosing periods, Xolair 150mg and 300mg were well-tolerated

Dupilumab Beneficial in Patients with Uncontrolled, Persistent Asthma

By September 12, 2017

Results found that at 52 weeks severe asthma attacks were reduced by 46% in the overall population for the 300mg dose group and by 60% and 67% among those patients with ≥150 eosinophilic cells/microliter or greater and ≥300 eosinophilic cells/microliter, respectively (P<0.001).

FDA Approves Inhaler Monitoring Device for Symbicort

By September 06, 2017

The SmartTouch for Symbicort is a monitoring device that is installed onto the patient's inhaler to track and improve medication adherence.

Do Inhaled Corticosteroids Up Pneumonia Risk in Children with Asthma?

February 27, 2017

No increased risk of pneumonia; no link for ICS with risk of pharyngitis, otitis media, sinusitis

Spiriva Respimat Gets Expanded Approval for Pediatric Asthma Maintenance

By February 16, 2017

This approval was based on efficacy and safety data from the Phase 2 and Phase 3 UniTinA-asthma clinical development program.

Two New Breath-Activated Inhalers Gain FDA Approval for Asthma

By January 30, 2017

AirDuo RespiClick and ArmonAir RespiClick are expected to be available later this year.

Symbicort Gains New Pediatric Indication for Asthma

By January 30, 2017

The pediatric approval was based on the results of the Phase 3 CHASE (ChildHood Asthma Safety and Efficacy) 3 trial.

Fish Oil Fatty Acids in Pregnancy Cut Wheeze, Asthma Risk in Child

December 28, 2016

Supplementation in pregnancy linked to reduction in risk of persistent wheeze and asthma in offspring

Fewer ED Visits for Asthma Following Indoor Smoking Ban

By December 28, 2016

Over the last 30 years, cities and states have adopted legislation to ban smoking in public indoor areas to protect nonsmokers from the adverse effects of secondhand smoke.

Eating Cured Meat May Worsen Asthma Symptoms

December 21, 2016

Intake levels also have, to a lesser extent, an effect mediated by body mass index

Evidence Supports Intermittent ICS to Prevent Wheeze Exacerbations in Preschoolers

May 31, 2016

There is strong evidence to support intermittent inhaled corticosteroids (ICS) for prevention of wheeze exacerbations in preschool children with intermittent asthma or viral-triggered wheezing, according to a review published online in Pediatrics.

Researchers Find Urine Metabolomics May Act as Asthma Identifier

May 23, 2016

Increased urine metabolomic lipid metabolites are associated with clinical parameters in non-obese asthma patients, according to a study published online May 18 in Allergy.

Does the Risk of Asthma-Related Events Go Up with Salmeterol +Fluticasone vs. Fluticasone Alone?

By March 07, 2016

The risk of serious asthma-related events was no greater with the combination of long-acting beta-agonist (LABA) salmeterol + the inhaled glucocorticoid, fluticasone propionate, versus fluticasone alone.

Does Having Asthma Up the Risk of Abdominal Aortic Aneurysm?

February 12, 2016

Asthma is associated with increased risk of abdominal aortic aneurysm (AAA) and rupture, according to research published online in Arteriosclerosis, Thrombosis, and Vascular Biology.

Does Having a Respiratory Condition Lower the Risk of Glioma?

February 08, 2016

Patients with respiratory allergies, asthma, and eczema may be less likely to develop a glioma, according to a study published in the February issue of Cancer Epidemiology, Biomarkers & Prevention.